Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial

BACKGROUND: The Anemia Studies in chronic kidney disease (CKD): Erythropoiesis via a Novel prolyl hydroxylase inhibitor Daprodustat-Dialysis (ASCEND-D) trial will test the hypothesis that daprodustat is noninferior to comparator epoetin alfa or darbepoetin alfa for two co-primary endpoints: hemoglob...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Ajay K, Blackorby, Allison, Cizman, Borut, Carroll, Kevin, Cobitz, Alexander R, Davies, Rich, Jha, Vivekanand, Johansen, Kirsten L, Lopes, Renato D, Kler, Lata, Macdougall, Iain C, McMurray, John J V, Meadowcroft, Amy M, Obrador, Gregorio T, Perkovic, Vlado, Solomon, Scott, Wanner, Christoph, Waikar, Sushrut S, Wheeler, David C, Wiecek, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035347/
https://www.ncbi.nlm.nih.gov/pubmed/33744933
http://dx.doi.org/10.1093/ndt/gfab065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035347/
https://www.ncbi.nlm.nih.gov/pubmed/33744933
http://dx.doi.org/10.1093/ndt/gfab065

Ejemplares similares